APA

Franchi F., Rollini F., Kairouz V., Rivas Rios J., Rivas A., Agarwal M., Briceno M., Wali M., Nawaz A., Silva G., Shaikh Z., Maaliki N., Been L., Piraino J., Pineda A. M., Suryadevara S., Soffer D., Zenni M. M., Jennings L. K., Bass T. A. & Angiolillo D. J. (2019). Pharmacodynamic Effects of Vorapaxar in Patients With and Without Diabetes Mellitus: Results of the OPTIMUS-5 Study. : JACC. Basic to translational science.

Chicago

Franchi Francesco, Rollini Fabiana, Kairouz Victor, Rivas Rios Jose, Rivas Andrea, Agarwal Malhar, Briceno Maryuri, Wali Mustafa, Nawaz Ahmed, Silva Gabriel, Shaikh Zubair, Maaliki Naji, Been Latonya, Piraino Jason, Pineda Andres M, Suryadevara Siva, Soffer Daniel, Zenni Martin M, Jennings Lisa K, Bass Theodore A and Angiolillo Dominick J. 2019. Pharmacodynamic Effects of Vorapaxar in Patients With and Without Diabetes Mellitus: Results of the OPTIMUS-5 Study. : JACC. Basic to translational science.

Harvard

Franchi F., Rollini F., Kairouz V., Rivas Rios J., Rivas A., Agarwal M., Briceno M., Wali M., Nawaz A., Silva G., Shaikh Z., Maaliki N., Been L., Piraino J., Pineda A. M., Suryadevara S., Soffer D., Zenni M. M., Jennings L. K., Bass T. A. and Angiolillo D. J. (2019). Pharmacodynamic Effects of Vorapaxar in Patients With and Without Diabetes Mellitus: Results of the OPTIMUS-5 Study. : JACC. Basic to translational science.

MLA

Franchi Francesco, Rollini Fabiana, Kairouz Victor, Rivas Rios Jose, Rivas Andrea, Agarwal Malhar, Briceno Maryuri, Wali Mustafa, Nawaz Ahmed, Silva Gabriel, Shaikh Zubair, Maaliki Naji, Been Latonya, Piraino Jason, Pineda Andres M, Suryadevara Siva, Soffer Daniel, Zenni Martin M, Jennings Lisa K, Bass Theodore A and Angiolillo Dominick J. Pharmacodynamic Effects of Vorapaxar in Patients With and Without Diabetes Mellitus: Results of the OPTIMUS-5 Study. : JACC. Basic to translational science. 2019.